SAN DIEGO, Nov. 7, 2013 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today that it will be participating in the Canaccord Genuity 2013 Medical Technology & Diagnostics Forum on Thursday, November 14.
The presentation by John Dahldorf, chief financial officer, will begin at 10:30 a.m., Eastern Standard Time (7:30 a.m., Pacific Standard Time). The presentation will be available through http://wsw.com/webcast/canaccord12/ and via the company’s website at www.volcanocorp.com.
Volcano Corporation is revolutionizing the medical device industry with a broad suite of technologies that make imaging and therapy simpler, more informative and less invasive. Our products empower physicians around the world with a new generation of analytical tools that deliver more meaningful informationusing light and sound as the guiding elements. Founded in cardiovascular care and expanding into other specialties, Volcano is changing the assumption about what is possible in improving patient outcomes by combining imaging and therapy together. For more information, visit the company’s website at www.volcanocorp.com.
SOURCE Volcano Corporation
Help employers find you! Check out all the jobs and post your resume.
